External photon radiation treatment for prostate cancer: Uncomplicated and cancer-free control probability assessment of 36 plans.

Normal tissue complication probability Prostate radiotherapy treatment Radiation protection of the patient Radiobiological modelling Radiotherapy plan optimisation Second primary cancer risk Tumour control probability

Journal

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
ISSN: 1724-191X
Titre abrégé: Phys Med
Pays: Italy
ID NLM: 9302888

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 16 07 2019
revised: 18 08 2019
accepted: 11 09 2019
pubmed: 2 10 2019
medline: 15 2 2020
entrez: 2 10 2019
Statut: ppublish

Résumé

To perform a systematic and thorough assessment, using the Uncomplicated and Cancer-Free Control Probability (UCFCP) function, of a broad range of photon prostate cancer RT treatments, on the same scenario (a unique pelvic CT set). UCFCP considers, together with the probabilities of local tumour control (TCP) and deterministic (late) sequelae (NTCP), the second primary cancer risk (SPCR) due to photon and neutron peripheral doses. Thirty-six radiotherapy plans were produced for the same CT. 6, 10, 15 and 18 MV 3DCRT, IMRT and VMAT (77.4 Gy in 43 fractions) and 6 and 10 MV SBRT (36.25 Gy in 5 fractions with flattened and FFF beams) for Elekta, Siemens and Varian Linacs plans were included. DVH and peripheral organ dosimetry were used to compute TCP, NTCP, and SPCR (the competition and LNT models) for further plan ranking. Biological models (and parameters) used predicted an outcome which is in agreement with epidemiological findings. SBRT plans showed the lowest SPCR and a below average NTCP According to UCFCP, the best plans were the10 MV SBRTs. SPCR rates were low and did not show a substantial impact on plan ranking. High energy intensity-modulated plans did not increase in excess the average of SPCR. Even more, they ranked among the best, provided that MU were efficiently managed.

Identifiants

pubmed: 31574423
pii: S1120-1797(19)30280-7
doi: 10.1016/j.ejmp.2019.09.076
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

88-96

Informations de copyright

Copyright © 2019 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.

Auteurs

B Sánchez-Nieto (B)

Instituto de Física, Pontificia Universidad Católica de Chile, Santiago, Chile. Electronic address: bsanchez@fis.puc.cl.

M Romero-Expósito (M)

Departament de Física, Universitat Autónoma de Barcelona, Bellaterra, Spain.

J A Terrón (JA)

Hospital Universitario Virgen Macarena, Sevilla, Spain.

L Irazola (L)

Departamento de Fisiología Médica y Biofísica, Universidad de Sevilla, Sevilla, Spain.

M T García Hernández (MT)

ERESA, Valencia, Spain.

J C Mateos (JC)

Departamento de Fisiología Médica y Biofísica, Universidad de Sevilla, Sevilla, Spain; Hospital Universitario Virgen del Rocío, Sevilla, Spain.

J Roselló (J)

ERESA, Valencia, Spain; Departamento de Fisiología, Universidad de Valencia, Spain.

D Planes (D)

ERESA, Valencia, Spain.

M Paiusco (M)

Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.

F Sánchez-Doblado (F)

Hospital Universitario Virgen Macarena, Sevilla, Spain; Departamento de Fisiología Médica y Biofísica, Universidad de Sevilla, Sevilla, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH